NeuroOne Medical Technologies Corp. (NMTC)
0.8427
+0.01
(+1.23%)
USD |
NASDAQ |
Mar 06, 16:00
0.834
-0.01
(-1.03%)
Pre-Market: 20:00
NeuroOne Medical Technologies Cash from Investing (Annual) : -0.0817M for Sept. 30, 2025
Cash from Investing (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Annual) Benchmarks
| Zimmer Biomet Holdings, Inc. | -1.976B |
| Artivion, Inc. | -42.04M |
| Edwards Lifesciences Corp. | -946.60M |
| PetVivo Holdings, Inc. | -0.5634M |
| Nutriband, Inc. | -0.092M |